Research peptides1 specification

Cerebrolysin

Name: Cerebrolysin
Brand: SUN Peptides
SKU: CBL60

COA on request

Cerebrolysin: A neuroprotective and cognitive-enhancing peptide preparation. It is derived from brain proteins and has been studied for its ability to support nerve repair, improve cognitive function, and protect brain cells from damage. Often used in research related to stroke recovery, traumatic brain injury, and age-related cognitive decline.

Wholesale quote requiredPrice confirmed by sales

Choose specification

Selected SKU: CBL60
Pack: 60 mg x 10 vials
Status: Available for inquiry

No payment is taken online. Sales confirms availability, documentation, shipping, and commercial terms.

Purity>99%Estimated delivery: within one week after the order is placed.

COA is available on request

COA files are available in the document library; additional batch-specific documentation can be requested with your inquiry. Each batch is tested with HPLC purity analysis (≥99%). For MSDS or detailed storage protocols, please contact our sales team.

Order formatOne box accepted

DeliveryWithin one week after order

ShippingShipping and duties included

DocumentationCOA available on request

Research effects

In traumatic brain injury (TBI) treatment, patients receiving Cerebrolysin showed significant improvements in Glasgow Coma Scale (GCS) and Glasgow Outcome Scale (GOS) scores. A 6-month prospective study of 340 patients with moderate TBI complicated by intracerebral hemorrhage demonstrated that the Cerebrolysin group had superior improvement on the Coma Recovery Scale-Revised (CRS-R) (20.3±2.7 vs 16.4±2.1), with significantly higher 6-month survival rates (59.4% vs 27.8%) and no increased risk of adverse events. In acute ischemic stroke patients, Cerebrolysin as adjunctive therapy significantly improved motor function with rapid onset, facilitating accelerated recovery. In intensive care unit patients with delirium, 50mL Cerebrolysin daily for 7 consecutive days reduced delirium severity and improved cognitive function. A comparative study confirmed that among similar peptide preparations, Cerebrolysin is the only product capable of inducing Neurofilament-L expression with confirmed neurotrophic activity.

Research mechanism

Cerebrolysin exerts neuroprotective effects through multiple pathways. In cerebral ischemia-reperfusion injury, it reduces excitotoxic damage by inhibiting excessive activation of the NMDA receptor NR2B subunit and downregulating key apoptotic proteins including JNK, PTEN, Calpain, and Caspase-3. In traumatic brain injury, Cerebrolysin suppresses the TLR2/TLR4 signaling pathway, reducing levels of inflammatory cytokines including TNF-α, IL-1β, IL-6, and NF-κB, while upregulating tight junction protein ZO-1 expression to protect blood-brain barrier integrity. It also reduces neuronal apoptosis by regulating the Bcl-2/Bax ratio and decreasing Caspase-3. Additionally, it possesses antioxidant properties, improving post-ischemic neuronal dysfunction and enhancing neuroplasticity.

Product details

Key identity and handling information for the selected research material.

Material identity

Composition is process-dependent. Manufacturer, source material, molecular-weight profile, concentration, and batch documentation are central purchasing checks.

Storage guidance

Store unopened material in its original sealed packaging, protected from light, moisture, and repeated temperature changes. Follow the product label and batch document for the exact storage temperature. After opening or preparation, use only a validated laboratory storage protocol.

Quality review

Report a quality concern within 14 days of delivery with the order, batch details and available photos.

Resolution

When a quality claim is approved, choose a full refund or replacement shipment.

24/7 WhatsApp contact

Sales support remains available for product, documentation and wholesale inquiry follow-up.

CBL6060 mg x 10 vials